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Abstract:  A new compound (1) (named as artemceramide-B) together with eight known compounds (taraxerol 
(2), taraxerol acetate (3), ȕ-sitosterol (4), stigmasterol (5), trans-ethyl caffeate, dracunculin (7), scoparone (8) 
and isoscopoletin (9) were isolated from an ethanolic extract of the roots of Artemisia incisa Pamp (Asteracae). 
The structures of the compounds were determined through IR, 1D NMR (1H NMR, 13C NMR) and 2D NMR 
(COSY, NOESY, HSQC and HMBC) analyses. Accurate mass analyses were done with EI-MS, ESI-MS and 
acid methanolysis of compound 1 followed by GS-MS studies. The relative stereochemistry of artemceramide-B 
was determined by comparing its specific rotation and spectroscopic data with the literature. Compounds 1-9 
were tested for their anti-bacterial potential against five bacteria strains; Staphylococcus epidermidis, 
Staphylococcus aureus, Klebsiella pneumoniae, Bacillus subtilis and Escherichia coli. Compound 1 (new) (MIC: 
0.0157, 0.0313 mg/mL) and 7 (MIC: 0.0815, 1.000 mg/mL) showed excellent activities against S. epidermidis 
and S. aureus while compound 9 showed excellent activities (MIC: 0.0700, 1.234, 1.890 and 2.286 mg/mL) 
against S. epidermidis, S. aureus, K. pneumoniae and E. coli, respectively. Compound 6 (MIC: 2.000 mg/mL) 
was found to be active against E. coli while neither of the compounds showed potential activity against 
B. subtilis.  
 




Artemisia belongs to the most assorted genus of the family Asteraceae, consisting of over 500 
species, with 38 species reported in Pakistan [1]. Various classes of secondary metabolites including 
oxygenated aliphatic hydrocarbons, phenolic hydrocarbons, polyacetylenes, furans, terpenes, 
flavonoids, coumarins and alkamides are reported from Artemisia [2]. Most of the Artemisia 
compounds are pharmacologically reported as antimalarial, antihyperglycemic, antiulcerogenic, 
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antihistamine, antispasmodic, antifungal, antibacterial, antioxidant, antiallergic, insecticidal, 
anticancer and anthelmintic [3]. More than 1000 biodynamic compounds have been reported from the 
genus so for [4]; we are reporting the ceramides class for the first time from A. incisa. The ceramides, 
cerebrosides, sphingosine, glycospingolipids and sphingomyelin derivatives (sphingolipids) are 
essential part of the eukaryotic cell membrane and play a key role in the antigen antibody reactions 
and transmission of biological information [5]. Recently, some sphingolipids have shown anti-tumor, 
cytotoxic, immunostimulatory, anti-hepatotoxic, antiviral, antifungal, anti-ulcergenic and Ca2+-ATPase 
activities [6-7].  
We are reporting the isolation and structural elucidation of a new compound; named as 
artemceramide-B (1) together with known compounds 2-9 from A. incisa and the antibacterial 
screening (sensitivity and MIC mg/mL) of the compounds 1-9 against Staphylococcus epidermidis, 
Staphylococcus aureus, Klebsiella pneumoniae, Bacillus subtilis and Escherichia coli.  
 
2. Materials and Methods 
 
2.1. Plant collection and Identification 
 
The roots of Artemisia incisa were collected in October, 2010 from Dir (lower), Pakistan. The 
plant was identified by Prof. Dr. Tanveer Akhtar, Department of Botany, University of Kashmir, 
Muzaffarabad, Pakistan. The plant specimen (voucher # Bot. 2020 (PUP) was deposited in herbarium 
of the Department of Botany, University of Peshawar, Khyber Pakhtunkhwa, Pakistan.  
2.2. Extraction, fractionation and isolation from the roots of Artemisia incisa 
 
 Air dried roots (1.5 kg) of Artemisia incisa were macerated in 5 L of methanol for seven days. 
The extract was concentrated under vacuo, yielding a gummy residue (72 g) which was subjected to 
silica gel vacuum liquid chromatography (VLC), eluted with dichloromethane followed by methanol 
yielding fractions of dichloromethane (24 g) and methanol (14 g) respectively. 
The dichloromethane fraction (24 g) was subjected to silica gel column chromatography (CC) 
eluted with n-hexane:ethyl acetate (10:0, 9:1.5, 8:3 and 6:4), yielding five sub-fractions A-E. The sub-
fraction A (0.8 g) was a mixture of oxygenated hydrocarbons and was not pursued further. The sub-
fractions B (4.5 g) and C (5.7 g) were combined and subjected to CC, eluted with n-hexane:ethyl 
acetate (8:1.5, 8:2, 7:2.5, 7:3), yielding compounds 2 (55 mg), 3 (80 mg), 4 (38 mg) and 5 (105 mg) 
respectively. The sub-fraction D (2.3) was passed through sephadex LH-20 column eluted with 
dichloromethane:methanol (5:5), yielding compounds 6 (12 mg) and 7 (4 mg). The sub-fraction E (8.2 
g) was subjected to CC eluted with n-hexane:ethyl acetate (6:3.8), yielding compound 8 (14 mg). The 
methanolic fraction (14 g) on CC eluted with n-hexane:ethyl acetate (5:4), yielding compound 9 (15 
mg) while further elution with dichloromethane:methanol (9:1), yielding a new compound 1 (20 mg). 
2.3. Antibacterial sensitivity testing of the compounds (1-9) 
     The antibacterial activity against the five selected bacterial strains was performed using the agar 
well diffusion method of Akinpelu [16]. Using 1 mL pipette, about 0.2 mL of the broth culture of the 
test organisms on to the sterile molten test agar at 45Û&  P/)(diagnostic sensitivity test agar, 
Biotech Ltd.). The agar prepared was decanted into sterilized labeled (with type of the pathogen) Petri 
dishes. On solidification a required number of holes of about 5 mm were made. The solution of the 
compounds were added to the wells using Pasteur pipettes. Streptomycin phosphate (1.0 mg/mL) was 
XVHGDVDVWDQGDUG7KHSODWHVDIWHUKRXUVZHUHLQFXEDWHGIRUKRXUVDWÛ&7KHSODWHVZHUHWKHQ
VWUHDNHG ZLWK GULHG EDFWHULDO LVRODWHV DQG LQFXEDWHG DW  Û& $Iter 72 hours, the clear zone of 
inhibition was measured in mm and same procedure was employed for all the compounds (1-9). 
  





Figure 1. Structures of the compounds 1-9 
2.4.  Determination of minimum inhibitory concentration (MIC mg/mL) of the selected 
compounds (1, 6, 7 and 9) 
The minimum inhibitory concentration (MIC) for some of the more active compounds (1, 6, 7 
and 9) was determined using the method of Russell and Furr [17]. various concentrations (0.0078 - 
1.000 mg/mL) of the compounds (1, 6, 7 and 9) in DMSO (solvent) were prepared using a two-fold 
dilution method. Then the procedure given above was followed. The lowest concentration preventing 
the growth was taken as the MIC for the compound.  
2.5.  General experimental procedures 
Column chromatography (CC) was performed on silica gel (60-200 mesh, Merk, Germany) 
and Sephadex LH-20 (Amersham Biosciences, Sweden). Thin layer chromatography (TLC) was done 
on precoated sheets of silica gel (0.20 mm thick, 20î20 cm, Merck, Germany) on aluminum backing. 
Visualization of spot on TLC was done using vanillin/H2SO4 or ceric sulphate reagents followed by 
heating. The ID and 2D NMR data were obtained with a Bruker instrument (Avance DRX-500, 
Germany) operating at a frequency of 500.13 (1H) and 125.62 MHz (13C) at a temperature of 296.0 K. 
Optical rotations were measured with a Perkin-Elmer 243B polarimeter (USA) in pyridine
  
and 
methanol at 25 &. IR spectra were recorded with a Nicolet Avatar FT-IR spectrophotometer (Thermo 
scientific, USA). The positive ESI-MS data were obtained with a LCQ fleet LC-MS system by direct 
inlet using methanol as a solvent (Thermo scientific, USA). The EI-MS and GC analyses were done 
with a Shimadzu QP-5000 instrument [GC conditions: DB-1 capillary column  P î 0.25 mm); 
injector temperature, 270 &; column temperature, 60-260 &;  temperature increase rate, 10 & min-1; 
He at 15 mL min]. 
2.6. The methanolysis of compound 1 
Compound 1 (14 mg) was refluxed with 80 % aqueous methanol (16 m1) and 1.0 N HCl 
(3mL) at 85 &for 18 h. the components of the mixture were compared on TLC using MeOH:CH2Cl2 
(1:9). The Rf values of artemceramide-B (1), long chain base (LCB) and fatty acid methyl ester 
(FAME) were 0.55, 0.35 and 0.91 respectively. The solution obtained was extracted three times with 




n-pentane. The n-pentane solution was dried over anhydrous Na2SO4 and then concentrated under 
vacuo, yielding a FAME (6.5 mg). The FAME was subjected to GC-MS analysis, Peak l (tR 14.26 min, 
1.2 %, 2-hydroxypalmitic acid methyl ester), El-MS m/z: 286 [M]+(2), 268 [M-H2O]+ (0.5), 227 [M-
CH3OCO]+ (8), 208 (1), 182 [M-CH3OCO-CH2OHCH2]+ (0.5), 159 (1), 145(2), 127 [C9H19]+ (3), 125 
(4), 111 (6), 97 (20), 90 [CHOC(OH)=CHOH]+ (21), 83 (27), 69 (30) and 57 (81). The FAME was 
obtained as a white amorphous powder, m.p. 76 &. The specific rotation of the FAME; 25>Į@D -5.0 (c 
0.1, chloroform) was compared with the reported analogues RI Į-hydroxy fatty acid methyl ester 
having levo (-) specific rotation and an absolute Rectus FRQ¿JXUDWLRQ (R) [15], therefore, the structure 
of FAME was elucidated as (R)-2-hydroxypalmitic acid methyl ester [14]. 
 
3.  Results and Discussion  
 
3.1. Structure elucidation 
Phytochemical investigation of dichloromethane and methanol fraction of A. incisa resulted in 
the isolation of  a new compound; artemceramide-B (1) (Figure 2) and eight known compounds; 
taraxerol acetate (2) [8], taraxerol (3) [9], stigmasterol (4) >@ ȕ-sitosterol (5) [11], trans-ethyl 
caffeate (6), dracunculin (7) [12], scoparone (8) [13], and isoscopoletin (9) [13] (Figure 1). The plant 
of A. incisa was phytochemically unexplored, however, among the biological activities, in vitro 
assessment of the protection from oxidative stress by various fractions of the extract of Artemisia 
incisa have been reported [18]. 
Compound 1 was obtained as a white amorphous powder, m.p. 141±142 &and 20>Į@D +7.98 
(c 0.07, pyridine). The molecular formula of C44H89NO5 was deduced from HR-ESIMS (positive ion 
mode) which showed the pseudo molecular ion peak at m/z 712.6093 [M+H]+. The IR showed 
absorptions for NH st. at 3401, OH st. at 3365.4, 3328.5, 3246.6 and 3218.6, CONH
 
st. at 1621.8 and 
(CH2)n st. at 963.3, 720.3 cm.-1 The 1H and 13C NMR (Table 1) spectra of compound 1 gave signals 
characteristics of two long chain aliphatic moieties which consist of methylenes (įH 1.26, 56H, m, 
1.78, 4H, m and 1.70, 4H, m; įC 29.16±29.99, 31.92 and 22.58) and two terminal methyls (įH 0.84, 
6H, t, J = 7.0 Hz; įC 13.77) linked through a secondary amide linkage (įH 8.59, 1H, d, J = 9.0 Hz; įC 
174.95), proposing the structure nature of ceramide. This was further supported by methanolysis of 
compound 1, yielding DORQJFKDLQEDVH/&%DQGĮ-hydroxy fatty methyl ester (FAME). On GC-MS 
analysis, the FAME was determined to be methyl 2-K\GUR[\SDOPLWDWH>@WKHDEVROXWHFRQ¿JXUDWLRQ
at C-2 was determined to be RIURPWKHVSHFL¿FURWDWLRQ20>Į@D -1.40 (c 0.10, chloroform) [15]. The 
characteristic 1H and 13C NMR signals for diastereotopic oxymethylene (įH 4.51, 1Ha, dd, J = 10.5, 5.0 
Hz and 4.43, 1Ha, dd, J = 10.5, 5.0 Hz; įC 61.74), an amidomethine (įH 5.11, 1H, m; įC 52.69), 
oxymethines (įH 4.36, 1H, dd, J = 11.0, 4.5 Hz and 4.30, 1H, m; įC 76.54 and 72.72), diastereotopic 
methylene (įH 1.98, 1Ha, m and 2.19, 1Hb, m; įC 33.84), methylene (įH 2.2.1, 2H, m; įC 26.36) and 
hydroxyl protons (6.25, 1H, br. s; 6.71, 1H, br. s and 6.72, 1H, br. s), proved the presence of 
phytosphingosine moiety. Similarly, the characteristic 1H and 13C NMR signals for oxymethine (įH 
4.62, 1H, dd, J = 7.6, 3.5 Hz; įC 72.16), diastereotopic methylene (įH 2.20, 1Ha, m and 2.23, 1Hb, m; įC 35.37), methylene (įH 1.98, 1H, m; įC 25.48) and hydroxyl proton (įH 7.65, 1H, br. s) showed the 
SUHVHQFHRIĮ-hydroxy fatty acid moiety. 
In the COSY (1H-1H) spectrum, the amidomethine proton at įH 5.11 (H-2) showed cross peaks 
with the diastereotopic oxymethylene protons at įH 4.51; 4.43 (2H-1), amidoproton at įH 8.59 (NHCO) 
and oxymethine
 
proton at įH 4.36 (H-3). The oxymethine proton at įH 4.36 (H-3) have correlation with 
the oxymethine proton at įH 4.30 (H-4). In the HMBC spectrum, the hydroxyl protons at įH 6.25, and 
6.71, 6.72 showed 2J correlations with the carbons at įC 61.74 (C-4) and 76.54 (C-2), 72.72 (C-3) 
respectively which showed their corresponding position of attachment at sphingosine moiety. The 
amidomethine proton at įH 5.11 (H-2) showed 2J HMBC correlation with the carbons at įC 61.74 (C-1) 
and 76.54 (C-3) while 3J HMBC correlation with the carbon at įC 72.72 (C-4). Similarly, the 
oxymethine proton at įH 4.36 (H-3) showed 2J HMBC correlation with the carbons at įC 72.72 (C-4) 
and 52.69 (C-2) while 3J HMBC correlation with the carbons at įC 61.74 (C-1) and 33.84 (C-5). Thus 
both the COSY and HMBC correlations established the partial structure of sphingosine as 2-amido-
1,3,4-triol sphingosine. The hydroxyl protons at įH 7.65 showed correlation with the carbon at įC 72.16 




which showed their position of attachment at the Į-carbon (C-2ƍ) of fatty acid moiety. The oxymethine 
proton at įH 4.62 (H-ƍhave 2J HMBC correlation with the carbons at įC 174.95 (C-1ƍ) and 35.37 (C-
ƍ) while 3J HMBC correlation with the carbons at įC 25.48 (C-4ƍ). These correlations as well as the 3J 
HMBC correlation of the protons at įH 2.20; 2.23 (2H-ƍZLWKWKHcarbonyl at įC 174.95 (C-ƍ showed 
the presence of Į-hydroxy fatty acid moiety. In the COSY spectrum, the oxymethine proton at įH 4.62 
(H-ƍshowed cross peaks with the diastereotopic methylene protons at įH 2.20; 2.23 (2H-ƍ which 
proved the presence oIĮ-hydroxy fatty acid moiety. The amide linkage between the sphingosine and 
fatty acid moieties was deduced from the HMBC correlation of the NH proton at įH 8.59. The NH 
proton showed 2J correlation with the carbons at įC 52.69 (C-2) and 3J correlation with the carbons at įC  61.74 (C-1) and 76.54 (C-3) of sphingosine moiety. Similarly the NH proton showed 2J correlation 
with the carbonyl at įC 174.95 (C-ƍ) of fatty acid moiety.  
The EI-MS of the FAME obtained from the methanolysis of compound 1 gave [M]+ at m/z 
286 corresponding to (R)-2-hydroxypalmitic acid methyl ester [14]. Therefore, the phytosphingosine 
moiety was declared to be a C28 aliphatic-1,2,3-triol amine (2-aminooctacosane-1,3,4-triol). 
            The NOESY correlation of compound 1 showed two groups of protons; (H-2, H-ƍ, H-4, OH-
3ƍ) and (H-3, OH-4, OH-ƍ, NH-ƍ) while the optical rotation of compound 1 was recorded as 20>Į@D 
+7.98 (c 0.07, C5H5N). 
 So, by comparing the data obtained from optical rotation and NOESY correlations (Figure 
3) as well as the characteristic 13C NMR chemical shifts of compound 1 (at carbons; C-ƍ, C-
ƍ , C-1 (61.74), C-2 (52.69), C-3 (76.54) and C-4 (72.72) (Table 1) with the ceramide 
analogue; (R)-2-hydroxy-N-((2R,3R,4S)-1,3,4-trihydroxynonacosan-2-yl-pentacosanamide, 20>Į@D 
+10.2 (c 0.09, C5H5N) [15] it was deduced that the relative FRQ¿JXUDWLRQVDW WKHFDUERQV&-2, C-3, 
and C-4 of sphingosine moiety of compound 1 were 2R, 3R, and 4S respectively. 
 The overall information obtained from the physicochemical constants and spectral data of IR, 
ESI-MS, EI-MS, 1D- and 2D-NMR, acid-methanolysis followed by GC-MS analyses, the structure of 
compound 1 was established as (ƍ5)-ƍ-hydroxy-2N-((2R,3R,4S)-1,3,4-trihydroxyoctacosan-2-
yl)hexadecanamide. The compound 1 was found to be new after searching the literature and named as 
artemceramide-B. The structure of artemceramide-B (1) along with important COSY, HMBC 
correlations are given in Figure 2 while NOESY correlations in Figure 3. 
3.2. Physical data of known compounds (2-9) 
 Compound 2 (taraxerol acetate) [8] was isolated as white crystals, m.p. 282±&OLWPS
282±&7KHPROHFXODUIRUPXODRI&32H52O2 was established from EI-MS with m/z 468.39 [M]+. 
Compound 3 (taraxerol) [9] was obtained as white crystals, m.p. 302-C (lit. m.p. 304±&
The molecular formula of C30H50O was established from EI-MS with m/z 426.38 [M]+. Compound 4 
(stigmasterol) [10] was isolated as white crystals, m.p. 165± & OLW PS ± & 7KH
molecular formula of C29H48O was established from EI-MS with m/z 412.37 [M]+. Compound 5 ȕ-
sitosterol) [11] was isolated as white crystals, m.p. 135± & OLW PS  & 7KH PROHFXODU
formula of C29H50O was established from EI-MS with m/z 414.39 [M]+. Compound 6 (trans-ethyl 
caffeate) [12] was obtained as white needles like crystals, m.p.148±&OLWPS±&7KH
molecular formula of C11H12O4 was deduced from EI-MS with m/z 208.073 [M]+. Compound 7 
(dracunculin) [12] was obtained as colorless needles, m.p. 220± & OLW PS ± &7KH
molecular formula of C11H8O5 was obtained from the EI-MS with m/z 220.037 [M]+. Compound 8 
(scoparone) [13] was isolated as greenish white needles, m.p. 143± & OLW PS  & 7KH
molecular formula of C11H10O4 was deduced from the EI-MS with m/z 206.058 [M]+. Compound 9 
(isoscopoletin) [13] was obtained as white yellow crystals, m.p. 184±&OLWPS&7KH
molecular formula of C10H8O4 was obtained from the EI-MS with m/z 192.042 [M]+. The complete 
structure assignments of the known compounds (2-9) were achieved by comparing their spectral data 










Table 1. 1H-NMR (500.13 MHz), 13C-NMR (152.62 MHz) data of compound 1 in pyridine-d5, į in 
ppm and J in Hz. 
Position įH      įC  
__________________________________________________________________________________
____ 
NH  8.59 (1H, d, J = 9.0)    --- 
1  4.51 (1Ha, dd, J = 10.5, 5.0);   61.74  
  4.43 (1Hb, dd, J = 10.5, 5.0)  
2  5.11 (1H, m)     52.69 
3   4.36 (1H, dd, J = 11.0, 4.5)   76.54 
4  4.30 (1H, m)     72.72 
5  1.98 (1Ha, m); 2.19 (1Hb, m)   33.84 
6  2.2.1 (2H, m)     26.36 
1-OH  6.71 (1H, br. s)    --- 
3-OH  6.72 (1H, br. s)  --- 
4-OH  6.25 (1H, br. s)    --- 
ƍ  ---     174.95 
ƍ  4.62 (1H, dd, J = 7.6, 3.5)    72.16  
ƍ  2.20 (1Ha, m); 2.23 (1Hb, m)   35.37  
ƍ  1.98 (1Hb, m)     25.48 
7±DQGƍ±ƍ 1.26 (56H, m)     29.16±29.99 
ƍ  1.78 (4H, m)     31.92    
ƍ  1.70 (4H, m)     22.58 
ƍ   0.84 (6H, t, J = 7.0)    13.77   
ƍ-OH 7.63 (1H, br. s)     ---
_________________________________________________________________________________ 
 
Figure 2. Important COSY (1H 1H) and HMBC (1H  13C) correlations of  
artemceramide-B (1) 
 
Figure 3. Important NOESY (1H  1H) correlations of artemceramide-B (1) 




3.3. Result of the antibacterial screening (sensitivity testing) and minimum inhibitory 
concentration for some selected compounds 
 
The analyses of data from the Table 2 and 3 showed that the new compounds 1 (MIC: 0.0157, 
0.0313 mg/mL) have enhanced potential against S. epidermidis and S. aureus as compared to 
streptomycin and tetracycline. The high potential of compound 1 might be due to the fact that it is a 
polar lipid bearing four hydroxyl groups and an amide linkage between two long aliphatic chains. The 
compound 9 showed high activity (MIC: 0.0700, 1.234, 1.890 and 2.286 mg/mL) against S. 
epidermidis, S. aureus, K. pneumoniae and E. coli respectively, which showed that coumarins bearing 
active phenolic groups might be the good choice against these bacterial strains. Compound 6 (MIC: 
2.000 mg/mL) was found to be active against E. coli while neither of the compounds showed good 
activity against B. subtilis. The sterols 4, 5 and triterpenes 2, 3 were found to be inactive. Due to very 
high potential of the compound 1 (MIC: 0.0157, 0.0313 mg/mL) and 9 (MIC: 0.0700, 1.234), it is 
recommended for in in-vivo testing against the bacterial strains of S. epidermidis and S. aureus. The 
reVXOWVDUHPHDQYDOXHVRI¿YHUHSOLFDWHV6'. 
Table 2.Result of the antimicrobial screening (sensitivity testing) of the compounds 1-9 against the 
five bacterial strains. 
Compound name         S. epidermidis S. aureus K. pneumoniae B. subtilis E. coli 
Zone of inhibition in mm at 2 mg/mL 
Artemceramide-B (1) 29 26 10 NA 16 
Taraxerol acetate (2) NA NA NA NA NA 
Taraxerol (3) NA NA NA NA NA 
Stigmasterol (4) NA NA NA NA NA 
ȕ-Sitosterol (5) NA NA NA NA NA 
trans-Ethyl caffeate (6) 09 NA 16 18 26 
Dracunculin (7) 17 20 10 15 18 
Scoparone (8) 14 12 NA 12 09 
Isoscopoletin (9) 28 20 16 14 18 
Streptomycin (1 mg/mL) 18 21 NA 20 NA 
Tetracycline (1 mg/mL) 12 NA 12 22 18 
NA = Not active 
Table 3. Minimum inhibitory concentrations (MICs) for some selected compounds 1, 6, 7 and 9 
against the five bacterial strains. 
Compound name S. epidermidis S. aureus K. pneumoniae B. subtilis E. coli 
MIC (mg/mL) 
Artemceramide-B (1) 0.0157 0.0313 NA NA NA 
trans-Ethyl caffeate (6) NA NA NA NA 2.000 
Dracunculin (7) 0.0815 1.000 NA NA NA 
Isoscopoletin (9) 0.0700 1.234 1.890 NA 2.286 
Streptomycin (mg/mL) 0.0625 1.000 NA 0.2500 NA 
NA = Not active 
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